Sector Chart 3billion, Inc.

Stocks

A394800

KR7394800007

Biotechnology & Medical Research

End-of-day quote Korea S.E. 09/09/2026			5-day change	1st Jan Change
4,600.00 ^KRW	-4.17%		-9.09%	-74.77%

06-01	3billion Launches 3B-NEO, Genomic Newborn Screening Service Covering 595 Clinically Actionable Genetic Conditions	CI
05-13	3billion, Inc. announced that it has received KRW 29.999999888 billion in funding from Meritz Securities Co., Ltd., Wonik Investment Partners Co., Ltd.	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Bio Diagnostics & Testing

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
3BILLION, INC.	114M	-	-	-	-	-
IOVANCE BIOTHERAPEUTICS, INC.	3.94B					-
ADAPTIVE BIOTECHNOLOGIES CORPORATION	3.88B					-
VERACYTE, INC.	3.41B
CAREDX, INC.	2.6B			-	-
BGI GENOMICS CO., LTD.	2.13B	-	-	-	-